Buradasınız

Anti-Nükleer Antikor Negatif Lupus ile Birlikte Görülen ‘Full-House Nefropati’ Olgusu

A Case of Full-House Nephropathy with Anti-Nuclear Antibody Negative Lupus

Journal Name:

Publication Year:

DOI: 
10.5262/tndt.2014.1002.17

Keywords (Original Language):

Abstract (2. Language): 
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the development of antibodies against a variety of nuclear and cytoplasmic antigens. SLE renal involvement is referred to as ‘lupus nephritis’ and is generally associated with anti-nuclear antibody (ANA) positivity. ANA is negative in approximately 5% of patients diagnosed with SLE. Existence of full-house nephropathy is generally associated with lupus nephritis. Herein, we present a case of full-house nephropathy in a 48-year-old male patient with negative serology for SLE. The patient had signs of lupus such as oral aphthae, symmetrical polyarthritis, and diffuse proliferative glomerulonephritis.
Abstract (Original Language): 
Sistemik lupus eritematozus (SLE), çeşitli nükleer ve sitoplazmik antijenlere karşı antikor gelişimi ile karakterize otoimmün bir hastalıktır. SLE renal tutulumu ‘lupus nefriti’ olarak adlandırılır ve genellikle anti-nükleer antikor (ANA) pozitifliği ile ilişkilidir. SLE tanısı konmuş hastaların yaklaşık %5’inde ANA negatiftir. Renal biyopside ‘full-house nefropati’ varlığı genellikle lupus nefriti ile ilişkilidir. Bu yazıda, ‘full-house nefropatisi’ olan ve SLE serolojisi negatif olmakla birlikte oral aft, simetrik poliartrit ve diffüz proliferatif glomerülonefrit gibi lupus belirtileri olan 48 yaşındaki bir erkek olgu sunulmuştur.
161
163

REFERENCES

References: 

1. Bagavant H, Deshmukh US, Gaskin F, Fu SM: Lupus
glomerulonephritis revisited 2004: Autoimmunity and end-organ
damage. Scand J Immunol 2004; 60: 52-63
2. Cobenas CJ, Spizziri FD, Drut R: Membranous nephropathy and
seronegative lupus erythematosus. Pediatr Nephrol 2003; 18: 202-
203
3. CK Sung, EWL Kun: A young lady with full-house nephropathy
and negative anti-nuclear antibody. Hong Kong Bull Rheum Dis
2009; 9: 23-25
4. Gianviti A, Barsotti P, Barbera V, Faraggiana T, Rizzoni G: Delayed
onset of systemic lupus erythematosus in patients with “full-house”
nephropathy. Pediatr Nephrol 1999; 13: 683- 687
5. Niaudet P: Treatment of lupus nephritis in children. Pediatr Nephrol
2000; 14: 158-166
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF,
Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for
the classification of systemic lupus erythematosus. Arthritis Rheum
1982; 25: 1271-1277
7. Maddison PJ, Provost TT, Reichlin M: Serological findings in
patients with “ANA negative” systemic lupus erythematosus.
Medicine 1981; 60: 87-94
8. Cohen AH, Zamboni L: Ultrastructural appearance and
morphogenesis of renal glomerular hematoxylin bodies. Am J
Pathol 1977; 89(1): 105-118
9. Mii A, Shimizu A, Masuda Y, Fujita E, Aki K, Ishizaki M, Sato
S, Griesemer A, Fukuda Y: Current status and issues of C1q
nephropathy. Clin Exp Nephrol 2009; 13(4): 263-274
10. Abrass CK, Nies KM, Louie JS, Border WA, Glassock RJ:
Correlation and predictive accuracy of circulating immune
complexes with disease activity in patients with systemic lupus
erythematosus. Arthritis Rheum 1980; 23(3): 273-282

Thank you for copying data from http://www.arastirmax.com